Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Natural Treatment

Research Leaders

18 sponsors active, led by Ann & Robert H Lurie Children's Hospital of Chicago

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

3Total
Phase 1/2 (1)
Phase 3 (1)
Phase 4 (1)

Trial Status

Completed3
Unknown2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT03830177Phase 1/2CompletedPrimary

Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult

NCT06578962CompletedPrimary

Efficacy of a Cosmetic Shampoo RV3438G in Reccurent Squamous States

NCT05225493Unknown

HIV Indicator Diseases in Hospital and Primary Care

NCT00703846Phase 4CompletedPrimary

STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%

NCT01011621Phase 3Unknown

Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis

Showing all 5 trials

Research Network

Common Treatments

  • Natural Treatment1
  • Phase 2 Neutral Shampoo1
  • Phase 1 Short Intensive Treatment Phase1
  • Ketoconazole1
  • Betamethasone Valerate1

Active Sponsors

  • Ann & Robert H Lurie Children's Hospital of Chicago1
  • Huisartspraktijk Gezondheidscentrum Mathenesserlaan1
  • Erasmus Medical Center1
  • Rijnstate Hospital1
  • Maasstadziekenhuis1

Top Investigators

Related Conditions

  • Psoriasis2
  • Hiv Infections1
  • Weight Loss1
  • Candida Infection1
  • Acquired Immunodeficiency Syndrome1

Activity Timeline